Press releaseGlobe Newswire
Onkure Therapeutics
OKUR · NASDAQ
$2.36+$0.11 (+4.89%)TodayMarket closed ·
Prev close $2.25
Latest news
- Press releaseGlobe Newswire
OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026
- Press releaseGlobe Newswire
OnKure Therapeutics Reports First Quarter 2026 Financial Results
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Press releaseGlobe Newswire
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseGlobe Newswire
OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
- Press releaseGlobe Newswire
OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update
- Press releaseGlobe Newswire
OnKure Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
- Press releaseGlobe Newswire
OnKure Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights
- Press releaseGlobe Newswire
OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
- Press releaseGlobe Newswire
OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
- NewsAvi Kapoor
This Builders FirstSource Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.